Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacoba P Greving

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Stroke|May 29, 2019
Comparison of Rupture Risk of Intracranial Aneurysms Between Familial and Sporadic PatientsLiselore A Mensing, Jacoba P Greving, Tessa A Verhoeff, et al.
European Stroke Journal|June 6, 2019
Nonfocal transient neurological attacks in patients with carotid artery occlusionEline A Oudeman, Eline J Volkers, Jacoba P Greving, et al.
Neurology|September 26, 2012
Predicting outcome after acute basilar artery occlusion based on admission characteristicsYingkun He, Tianxiao Li, Tianxio Li, et al.
Stroke|August 15, 2013
Cost-effectiveness of surgical decompression for space-occupying hemispheric infarctionJeannette Hofmeijer, H Bart van der Worp, L Jaap Kappelle, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 22, 2019
[The antithrombotic jungle: an overview of the recent literature]Geert-Jan Geersing, Jacoba P Greving, Richard Folkeringa, et al.
International Journal of Cardiology|January 8, 2018
Cost-effectiveness of PCSK9 inhibition in addition to standard lipid-lowering therapy in patients at high risk for vascular diseaseManon C Stam-Slob, Yolanda van der Graaf, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|February 10, 2023
A Delphi consensus checklist helped assess the need to develop rapid guideline recommendationsAimee Claire Kok-Pigge, Jacoba P Greving, Janke F de Groot, et al.
Journal of the American Heart Association|February 20, 2017
Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease PatientsManon C Stam-Slob, Yolanda van der Graaf, Jacoba P Greving, et al.
Diagnostic and Prognostic Research|April 23, 2020
Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?Gijs F N Berkelmans, Jacoba P Greving, Yolanda van der Graaf, et al.
Neurology|January 28, 2018
Early time course of major bleeding on antiplatelet therapy after TIA or ischemic strokeNina A Hilkens, Ale Algra, L Jaap Kappelle, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Stroke|May 29, 2019
Comparison of Rupture Risk of Intracranial Aneurysms Between Familial and Sporadic PatientsLiselore A Mensing, Jacoba P Greving, Tessa A Verhoeff, et al.
European Stroke Journal|June 6, 2019
Nonfocal transient neurological attacks in patients with carotid artery occlusionEline A Oudeman, Eline J Volkers, Jacoba P Greving, et al.
Neurology|September 26, 2012
Predicting outcome after acute basilar artery occlusion based on admission characteristicsYingkun He, Tianxiao Li, Tianxio Li, et al.
Stroke|August 15, 2013
Cost-effectiveness of surgical decompression for space-occupying hemispheric infarctionJeannette Hofmeijer, H Bart van der Worp, L Jaap Kappelle, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 22, 2019
[The antithrombotic jungle: an overview of the recent literature]Geert-Jan Geersing, Jacoba P Greving, Richard Folkeringa, et al.
International Journal of Cardiology|January 8, 2018
Cost-effectiveness of PCSK9 inhibition in addition to standard lipid-lowering therapy in patients at high risk for vascular diseaseManon C Stam-Slob, Yolanda van der Graaf, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|February 10, 2023
A Delphi consensus checklist helped assess the need to develop rapid guideline recommendationsAimee Claire Kok-Pigge, Jacoba P Greving, Janke F de Groot, et al.
Journal of the American Heart Association|February 20, 2017
Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease PatientsManon C Stam-Slob, Yolanda van der Graaf, Jacoba P Greving, et al.
Diagnostic and Prognostic Research|April 23, 2020
Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?Gijs F N Berkelmans, Jacoba P Greving, Yolanda van der Graaf, et al.
Neurology|January 28, 2018
Early time course of major bleeding on antiplatelet therapy after TIA or ischemic strokeNina A Hilkens, Ale Algra, L Jaap Kappelle, et al.
Pageof 8